logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics, Strengthening and Diversifying Oncology Portfolio

Jan 23, 2024•almost 2 years ago

Acquiring Company

Bristol Myers Squibb

Acquired Company

Mirador Therapeutics

LawrencevilleSan DiegoManufacturingHealth CareTherapeuticsBiotechnologyHealth Care

Description

Bristol Myers Squibb has successfully completed the acquisition of Mirati Therapeutics, Inc., further diversifying and strengthening its oncology portfolio. Through this acquisition, Bristol Myers Squibb has added the commercialized lung cancer medicine KRAZATI to its portfolio, as well as several promising clinical assets, reinforcing its commitment to delivering innovative treatments for cancer patients.

Company Information

Company

Bristol Myers Squibb

Location

Lawrenceville, New Jersey, United States

About

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

Related People

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed